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Micrarus fulviusAbstract One million people throughout the world are bitten yearly by poisonous snakes. Of this,
one-tenth died and three-tenth suffer some forms of disabilities. In view of this, anti-snake venoms
are currently being developed against viper and colubrid snake venoms using mice. Therefore, a new
algorithm for calculation of median lethal dose (LD50) and effective dose fifty (ED50) was developed
for Micrarus fulvius venom and antivenom respectively. This paper compared the formula of effec-
tive dose fifty (ED50) developed by Spearman and Karber with ideal median lethal dose (IMLD50)
formula developed by Saganuwan with a view to bringing out their difference and similarity in cal-
culation of ED50 that could be used to develop a new median lethal dose formula for calculation of
Micrarus fulvius venom in mice. The findings revealed that ED50 value (477 mg/kg) from Spearman
and Karber’s formula (ED50 ¼ logED50 ¼ logX100  logFDn ðRt n=2Þ is comparatively similar with
ideal median lethal dose value (428.75 mg/kg) from Saganuwan’s formula (MLD50 +MSD50/2).
The new LD50 formula (LD50 ¼ ED503
 Wm 104) yielded value (0.29 mg/kg) of comparative
significance with reported value (0.32 mg/kg). When ED50 is equal to 2LD50, the denominator of
ED50
3
becomes 2. In conclusion, the new formula would yield low doses of snake anti-venoms with
reduced possibility of hypersensitivity reaction.
 2016 Faculty of Veterinary Medicine, Cairo University. Production and hosting by Elsevier B.V. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Snakes are represented on earth today by some 3150 species
[1]. Of these 2700 species known as Caenophidia or ‘‘ad-
vanced snakes” with fangs, and venom glands [2]. Venomous
snakes are responsible for an estimated 75,000 human deathsannually [3]. In the United Sates approximately 45,000 snake
bites occur each year, of which about 8000 are by 20 species
of venomous snakes. Deaths do not exceed 10–12 per year [4].
Of hospitalized snakebite victims, 0.5% of bites were inflicted
by coral snakes, 7.3% by cottonmouths, 28.6% by copper
heads, 29.8% by unidentified snakes and 33% by rattlesnake
[5] with diamondbacks causing the most fatalities. More than
95% of bites occur between April and October and 77%
occur during day time [6]. Snake venom metalloproteinases
are responsible for major local symptoms in snakebite causing
2 S.A. Saganuwanhaemorrhage, oedema, hypotension, hypovolemia, inflamma-
tion and necrosis [7]. Because of considerable ophidic snake
bites, advances have been achieved in the production of new
antivenoms using new processes [8], Coral snake envenoma-
tion could be handled using medication [9]. Specific treat-
ments with antivenoms continue to be the chosen method as
it deactivates the venom [10]. Aguilar et al. [11] prepared
snake antivenom against Micranis fulvius in chicken (Gallis
domesticus) with median effective dose (ED50 = 477 mg/kg).
Because of hypersensitivity reactions that do result from
snake antivenom treatment, a new algorithm has been devel-
oped for calculation of median lethal dose (LD50) and effec-
tive dose fifty (ED50) for snake venom and antiveonom
respectively.2. Materials and methods
Reed and Muench [12] introduced arithmetical method for
determination of median lethal dose (LD50) in 1938 which
was modified by Saganuwan [13]. The possible modifications
involved calculating percent of test animals both that died
and survived at all the test dose levels. The average of a dose
that caused 50% death and another dose that caused 50%
survival gave a relatively ideal LD50. However, Aguilar
et al. [11] estimated effective dose fifty (ED50) of coral snake
antivenom according to the method of Spearman and Karber
[14] using mice of 18–20 g. Various antivenom concentrations
of 17.2, 8.6, 4.3, 21.5 and 5.3 mg per mouse weighing 20 g
were used for calculation of Ideal Median Lethal Dose
(IMLD50) proven to be comparatively similar to the Effective
Dose Fifty (ED50) calculated by Aguilar et al. [11] using
Spearman and Karber’s formula. ED50 was also used to
develop a new formula for calculation of median lethal dose
(LD50) of snake venom in mice.
) ED50 ¼ log ED50 ¼ logX100  logFD
n
ðRt n=2Þ
The ideal Median lethal Dose ¼MLD50 þMSD50
22.1. Definition of terms
ED50 = the 50% effective dose; logX100 = log dose giving
100% survival and having 100% survival for all higher doses;
logFD= the log dilution factor; N = number of mice used at
each dose level; R= the sum of mice surviving at every dose
level, the ED50 is the effective dose of (lgy) that will protect
50% of the mice population when injected with 3LD50s. Med-
ian lethal dose (MLD50) is the dose that kills 50% of test mice
whereas median survival dose (MSD50) is the dose survival by
50% of test mice.
2.2. Ideal median lethal dose (IMLD50) of snake venom is equal
to effective dose fifty (ED50) of snake antivenom in mice
The calculation done by Aguilar et al. [11] for determination of
ED50 is confirmed using Ideal Median Lethal Dose (MLD50)
formula of Saganuwan [13] proving that Spearman and Kar-
ber’s formula gives ED50 that approximates Ideal Median
Lethal Dose (LD50).2.3. Hypothesis
ED50 ¼ logED50 ¼ logX100  logFD
n
ð
X
t n=2Þ
¼MLD50 þMSD50
2
¼ ideal Median Lethal Dose ¼ ðIMLD50Þ2.4. Median Lethal Dose of Snake Venom Deduced from
Effective Dose Fifty (ED50) and Ideal Median Lethal Dose
(IMLD50)
Since ED50 is the effective dose of 1gy that will protect 50% of
the mouse population when injected with 3LD50, the LD50 of
venom in the present context should be determined as follows:
ED50 = 3LD50
LD50 ¼ ED503 (this cannot give correct LD50 value)
i. But there is need to know the weight of individual mouse
in gramme (Wm) in relation to that of human in kilo-
gramme (1000 g) since antivenom is developed for
human use.
ii. Also safety factor of 1/10 is considered for mouse as
compared to snake
) LD50 ¼ ED50
3
 
 Wm
1000
 1
10
LD50 ¼ ED50
3
 
Wm
LD50 ¼ ED50
3
 
Wm 104 mg=kg3. Results
Proof: Ideal Median Lethal Dose (IMLD50) of Snake Venom
is Equal to Effective Dose (ED50) of Snake Antivenom in Mice50:025:0
62:525:0 ¼ 25:037:5 ¼ 0:666 50:037:575:037:5 ¼ 12:037:5 ¼ 0:333
Dose log dose 21:5
8:6 ¼ 2:5
21.5 1.3324 log 2.5 = 0.39798.6 0.9344 0.333  0.3979
=0.398 0.1325007) 0.666  0.3989 = 0.265068
Antilog of 0.9344 + 0.265068 Antilog of 0.9344  0.1325007
=1.199468 =0.12380MLD50 = 15.82 mg/mouse =1.32MSD50 = 1.33 mg/mouseTherefore; IMLD ¼ MLD50þMSD502 ¼ 15:82þ1:332 ¼ 17:152
=8.75 mg/mouseProof: New Median Lethal Dose of Snake Venom Deduced
from Effective Dose Fifty (ED50) and Ideal Median Lethal
Dose (IMLD50)
The ED50 is the effective dose of Igy that will protect 50%
of the mouse population when injected with 3LD50 (Table 1).
Table 1 Effective dose fifty (ED50) of yielded antibodies (Igy coral snake antivenom neutralizing lethal toxic activity of coral snake
venoms) using Saganuwan method [12].
Total protein of antivenom
(mg/20 g mouse)
Log dose Cumulative
Dead Survived Dead Survived Total Mortality rate % Mortality % Survival
17.2 1.2355 0 8 0 8 8 0
8
0.0 100
8.6 0.9344 4 4 4 12 16 4
16
25.0 75
4.3 0.6334 8 0 12 12 24 12
24
50.0 50.0
21.5 1.3324 8 0 20 12 32 20
32
62.5 37.5
5.3 0.7242 8 0 28 12 40 28
40
70.0 30
The new algorithm for calculation of median lethal dose 3Average weighed mouse is 20 g) 8.575 mg? 20 g
x ? 1000 g
x ¼ 10008:57520 ¼ 428:75mg=kg ¼ IMLD50
But the ED50 reported by Aguilar et al. [1] is 477 mg/kg
But IMLD50 = 451.3 mg/kg
)
LD50 of the venom ¼ ED503 Wm 104 ¼ IMLD503 Wm 104
¼ 428:753  20 104
LD50 = 0.29 mg/kg
IMLD50 ’ ED50
) IMLD50 can be used to calculate ED504. Discussion
The IMLD50 (428.75 mg/kg) obtained in our present investiga-
tion is close to the ED50 value (477 mg/kg) reported by Aguilar
et al. [11] indicating that IMLD50 can be used to calculate
ED50 of snake antivenom. The two values are within the
acceptable ED50 ranges of other antivenoms tested on different
snake venoms [15]. Normally antivenoms are achieved by
immunizing horses with increasing doses of venom to obtain
a high-quality antibody titer [16]. But since the value of our
IMLD50 is little lower than that of Aguilar et al., it may con-
note that at lower level of ED50, low side effects including ana-
phylaxis may exist. The elevated concentrations of proteins,
which are not antibodies, existing in many antivenoms produce
most of these side effects [17]. Immunoglobulin (Igy) produce
antibody against M. isozomus [11] and Scolapadra gigaitea
toxin [18]. WHO [14] patented Sodium Silicate Complex
(SSC) which comprises Trimeric Sodium Silicate (Na2SiO3)
and Sodium Silicate Pentahydrate (Na2SiO3)5H2O using a rel-
atively ideal median lethal dose formula developed by Saganu-
wan [13] confirming the reliability, predictive validity and
precision of the formula. SSC has antivenomous activity
against Crotalus atrox, Agkistrodon contortrix contortrix
and Agkistrodon piscivorus leucostoma venoms [14] of our
estimated LD50 (0.29 mg/kg) using the new developed formula
agrees with the report of Aguilar et al. [11] indicating that the
LD50 of Micrarus fulvius in mice is 0.32 ± 0.12 mg/kg body
weight in mice.
Snake venoms are known to be the most complex of all nat-
ural venoms. They contain more than one hundred toxic and
non-toxic biological molecules [19]. The cell toxicity assay
has been adapted as an alternative to assess toxicity in animals[20]. In the 1960s and 1970s, mice became the universally
accepted test animals and comparative toxicity was expressed
as LD50. Since ideal median lethal dose is approximately equal
to effective safety dose fifty (ED50) of antivenom and now
LD50 formula is deduced from ED50, the two formulas can
be of great value in toxinology of snake venom and anti-
venom.5. Conclusion
In line with the principles of replacement, reduction and refine-
ment, ideal median lethal dose and new developed LD50 for-
mula can be of great use for assessment of snake antivenom
and snake venom respectively. In conclusion, the new formula
would yield low doses of snake anti-venoms with reduced pos-
sibility of hypersensitivity reaction.References
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